Hospital-acquired infection Diagnostics Market by Product - Global Opportunity Analysis and Industry Forecast, 2017-2023 - Product Image

Hospital-acquired infection Diagnostics Market by Product - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4403133
  • Report
  • Region: Global
  • 140 pages
  • Allied Analytics LLP
1 of 3
Hospital-acquired infections are type of infections acquired during hospitalization and are commonly known as nosocomial infection. These infections can be acquired in hospital, nursing home, rehabilitation facility, outpatient clinic, or other clinical settings. They can be acquired from an infected patient, outside environment, or from a staff of that facility. The hospital-acquired infection diagnostics market is primarily driven by the growth in awareness among healthcare workers and proposed government initiatives by many governmental organizations. Further, in developing economies such as China, India, and Brazil, the cleanliness and hygiene is minimum. Hence, it results in more hospital-acquired infections, which further increases the demand for hospital-acquired infection diagnostics. However, the decline in hospital-acquired infections in the developed countries such as the U.S., Germany, and the UK impedes the market growth. The hospital-acquired infection diagnostics market was valued at $2,571 million in 2016, and is expected to reach at $4,311 million by 2023, registering a CAGR of 7.5% from 2017 to 2023.

The hospital-acquired infection diagnostics market is segmented based on product, test type, application, infection type, end user and region. Based on product this market is segmented into instrument and reagents and consumables. Based on test type, the market is classified into molecular diagnostics, urinalysis, and immunoassay. Based on application, the market is divided into disease testing and drug resistance testing. Further, based on infection type, it is classified into hospital acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal Infections, urinary tract infections (UTI), and others. Based on end user this market is segmented into hospital, clinics, ambulatory surgery centres (ASC) and others. By region, the market is analysed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the global hospital-acquired infections market, with current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps understand the type of products and technologies used globally.
Key market players and their strategies are provided to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By Product

Instrument and Reagents
Consumables

By Test Type

Molecular Diagnostics
Urinalysis
Immunoassay

By Application

Disease Testing and
Drug-Resistance Testing

By Infection Type

Hospital Acquired Pneumonia
Bloodstream Infections
Surgical Site Infections
Gastrointestinal Infections
Urinary Tract Infections (UTI)
Others

End User

Hospital
Clinics
Ambulatory Surgery Centers (ASC)
Others

BY REGION

North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Argentina
Turkey
South Africa
Rest of LAMEA

KEY PLAYERS PROFILED

Abbott Laboratories
AdvanDX
Alere Inc.
AstraZeneca plc
Bayer Schering Pharma LLC
Becton Dickinson & Company
Cepheid Inc.
Roche AG
Daiichi Sankyo
Hologic, Inc.

The other players in the value chain include (profiles not included in the report)

GlaxoSmithKline plc
Johnson & Johnson
Merck & Co.
Meridien
Pfizer
Seegene
READ MORE
Note: Product cover images may vary from those shown
2 of 3
CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2 KEY BENEFITS

1.1.1. Secondary research
1.1.2. Primary research
1.1.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATORY FRAMEWORK
3.5. MARKET SHARE ANALYSIS, 2016
3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Rising geriatric population base
3.6.1.2. Demand of HAI diagnostics from middle and low-income countries
3.6.1.3. Development of technologically advanced diagnostic products

3.6.2. Restraints

3.6.2.1. Decreasing prevalence of nosocomial infections in the developed countries
3.6.2.2. Lack of awareness regarding HAI

3.6.3. Opportunities

3.6.3.1. Introduction of awareness programs by various organizations

CHAPTER 4 HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. INSTRUMENT

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. REAGENTS AND CONSUMABLES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

CHAPTER 5 HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY TEST TYPE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. MOLECULAR DIAGNOSTICS

5.2.1. Market size and forecast

5.3. IMMUNOASSAY

5.3.1. Market size and forecast

5.4. URINALYSIS

5.4.1. Market size and forecast

CHAPTER 6 HOSPITAL ACQUIRED INFECTION DIAGNOSTICS, BY APPLICATION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. DISEASE TESTING

6.2.1. Market size and forecast

6.3. DRUG-RESISTANCE TESTING

6.3.1. Market size and forecast

CHAPTER 7 HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY INFECTION TYPE

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. HOSPITAL ACQUIRED PNEUMONIA

7.2.1. Market size and forecast

7.3. BLOODSTREAM INFECTIONS

7.3.1. Market size and forecast

7.4. SURGICAL SITE INFECTIONS

7.4.1. Market size and forecast

7.5. GASTROINTESTINAL INFECTIONS

7.5.1. Market size and forecast

7.6. URINARY TRACT INFECTIONS (UTI)

7.6.1. Market size and forecast

7.7. OTHERS

7.7.1. Market size and forecast

CHAPTER 8 HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY END USER

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. HOSPITALS

8.2.1. Market size and forecast

8.3. CLINICS

8.3.1. Market size and forecast

8.4. AMBULATORY SURGERY CENTERS

8.4.1. Market size and forecast

8.5. OTHERS

8.5.1. Market size and forecast

CHAPTER 9 HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY GEOGRAPHY

9.1. OVERVIEW

9.1.1. Market size and forecast

9.2. NORTH AMERICA

9.2.1. Key market trends
9.2.2. Key growth factors and opportunities
9.2.3. North America Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Country
9.2.4. North America Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.2.5. North America Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.2.6. North America Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.2.7. North America Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.2.8. North America Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

9.2.8.1. U.S. Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.2.8.2. U.S. Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.2.8.3. U.S. Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.2.8.4. U.S. Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.2.8.5. U.S. Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.2.8.6. Canada Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.2.8.7. Canada Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.2.8.8. Canada Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.2.8.9. Canada Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.2.8.10. Canada Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.2.8.11. Mexico Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.2.8.12. Mexico Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.2.8.13. Mexico Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.2.8.14. Mexico Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.2.8.15. Mexico Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

9.3. EUROPE

9.3.1. Key market trends
9.3.2. Key growth factors and opportunities
9.3.3. Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Country
9.3.4. Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.3.5. Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.3.6. Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.3.7. Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.3.8. Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

9.3.8.1. Germany Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.3.8.2. Germany Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.3.8.3. Germany Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.3.8.4. Germany Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.3.8.5. Germany Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.3.8.6. UK Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.3.8.7. UK Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.3.8.8. UK Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.3.8.9. UK Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.3.8.10. UK Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.3.8.11. France Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.3.8.12. France Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.3.8.13. France Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.3.8.14. France Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.3.8.15. France Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.3.8.16. Italy Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.3.8.17. Italy Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.3.8.18. Italy Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.3.8.19. Italy Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.3.8.20. Italy Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.3.8.21. Spain Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.3.8.22. Spain Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.3.8.23. Spain Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.3.8.24. Spain Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.3.8.25. Spain Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.3.8.26. Rest of Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.3.8.27. Rest of Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.3.8.28. Rest of Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.3.8.29. Rest of Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.3.8.30. Rest of Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

9.4. ASIA-PACIFIC

9.4.1. Key market trends
9.4.2. Key growth factors and opportunities
9.4.3. Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Country
9.4.4. Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.4.5. Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.4.6. Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.4.7. Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.4.8. Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

9.4.8.1. Japan Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.4.8.2. Japan Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.4.8.3. Japan Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.4.8.4. Japan Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.4.8.5. Japan Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.4.8.6. India Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.4.8.7. India Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.4.8.8. India Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.4.8.9. India Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.4.8.10. India Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.4.8.11. China Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.4.8.12. China Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.4.8.13. China Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.4.8.14. China Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.4.8.15. China Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.4.8.16. Australia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.4.8.17. Australia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.4.8.18. Australia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.4.8.19. Australia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.4.8.20. Australia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.4.8.21. South Korea Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.4.8.22. South Korea Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.4.8.23. South Korea Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.4.8.24. South Korea Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.4.8.25. South Korea Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.4.8.26. Rest of Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.4.8.27. Rest of Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.4.8.28. Rest of Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.4.8.29. Rest of Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.4.8.30. Rest of Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

9.5. LAMEA

9.5.1. Key market trends
9.5.2. Key growth factors and opportunities
9.5.3. LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Country
9.5.4. LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.5.5. LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.5.6. LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.5.7. LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.5.8. LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

9.5.8.1. Brazil Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.5.8.2. Brazil Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.5.8.3. Brazil Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.5.8.4. Brazil Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.5.8.5. Brazil Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.5.8.6. Saudi Arabia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.5.8.7. Saudi Arabia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.5.8.8. Saudi Arabia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.5.8.9. Saudi Arabia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.5.8.10. Saudi Arabia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.5.8.11. South Africa Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.5.8.12. South Africa Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.5.8.13. South Africa Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.5.8.14. Rest of LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.5.8.15. Rest of LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.5.8.16. Rest of LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.5.8.17. Rest of LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.5.8.18. Rest of LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

CHAPTER 10 COMPANY PROFILES

10.1. ABBOTT LABORATORIES

10.1.1. Company overview
10.1.2. Company snapshot
10.1.3. Operating business segments
10.1.4. Business performance
10.1.5. Key strategic moves and developments

10.2. ADVAN DX

10.2.1. Company overview
10.2.2. Company snapshot
10.2.3. Operating business segments
10.2.4. Key strategic moves and developments

10.3. ALERE INC.

10.3.1. Company overview
10.3.2. Company snapshot
10.3.3. Operating business segments
10.3.4. Business performance
10.3.5. Key strategic moves and developments

10.4. ASTRAZENECA PLC

10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Operating business segments
10.4.4. Key strategic moves and developments

10.5. BAYER SCHERING PHARMA LLC

10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Operating business segments
10.5.4. Key strategic moves and developments

10.6. BECTON DICKINSON AND COMPANY

10.6.1. Company overview
10.6.2. Company snapshot
10.6.3. Operating business segments
10.6.4. Key strategic moves and developments

10.7. CEPHEID INC.

10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Operating business segments
10.7.4. Key strategic moves and developments

10.8. ROCHE AG

10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Operating business segments
10.8.4. Key strategic moves and developments

10.9. DAIICHI SANKYO

10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Operating business segments
10.9.4. Business performance
10.9.5. Key strategic moves and developments

10.10. HOLOGIC, INC.

10.10.1. Company overview
10.10.2. Company snapshot
10.10.3. Operating business segments
10.10.4. Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll